source
- GSK reports strong Phase 3 results for Ionis-licensed chronic hepatitis B therapyGSK disclosed data from two late‑stage trials of a chronic hepatitis B treatment it licensed from Ionis Pharmaceuticals. The studies evaluated the drug’s efficacy and safety in patients with chroni…
- Eli Lilly's obesity drugs Foundayo and Zepbound added to CVS Caremark formularyEli Lilly announced that its two flagship obesity treatments, the oral agent Foundayo and the injectable Zepbound, will be listed on CVS Caremark's drug formularies. The inclusion comes as the GLP…